Xylo Technologies Profit Margin

The latest profit margin for XYLO is -20.19% as of December 2024. That compares with -17.49% in the prior-year period — down 15.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Xylo Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, XYLO's profit margin moved from -17.49% to -20.19% — a 15.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xylo Technologies's valuation or profitability profile.

Against Healthcare companies, XYLO currently prints -20.19% for profit margin, while the sector average sits near 13.89%. That is roughly 245.3% below the sector mean. Large gaps often invite a closer look at Xylo Technologies's growth, margins, and balance sheet.

Profit Margin shows how effectively Xylo Technologies converts resources into returns. At -20.19%, XYLO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -17.49% in the prior-year period — down 15.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XYLO's profit margin (-20.19%), review year-over-year change from -17.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.